EUVIMEDEUVIMED entdecken
Crossref

Manipulating labile iron to enhance the therapeutic response of NSCLC to chemoradiation therapy

Khaliunaa Bayanbold

Iowa Research Online (The University of Iowa) · 31.10.2023

DOI: 10.25820/etd.006977 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Iowa Research Online (The University of Iowa), erschienen am 31.10.2023. Verfasst von Khaliunaa Bayanbold.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The redox-active, labile iron pool (LIP) plays a role in oxidative stress in cancer cells. An elevated LIP and abnormal iron metabolism have been associated with poor survival in lung cancer by unknown mechanisms. To evaluate the LIP in non-small cell lung cancer (NSCLC) cells, the iron storage protein ferritin heavy chain (Ft-H) was over-expressed using a doxycycline-inducible lentiviral vector (pCMV6-XL4/5/6) system, and cells were treated with the iron chelator deferoxamine (DFO). Overexpression of Ft-H and DFO treatment decreased both LIP and clonogenic cell survival in H1299, but only DFO was effective in both H1299 and A549 NSCLC-cells. Overexpression of Ft-H also inhibited cell growth and delayed transit through S-phase; one of these effects was partially reversed by supplementing iron with holo-transferrin in H1299 cells. Overexpression of DFO and Ft-H also induced single- and double-strand DNA breaks and sensitized both H1299 and A549 NSCLC cells to inhibitors of the repair of DNA damage by targeting ATM and ATR signaling pathways. This suggests a role for Fe chelation-induced DNA damage and replication stress. Interestingly, overexpression of Ft-H and DFO were also able to sensitize both lung cancer cell lines to chemo-radiation. Overall, these results support of the hypothesis that reduction of the size of the LIP can induce DNA damage, replication stress, cell death, and potentiate therapeutic responses to chemo-radiation therapy in NSCLC.

Schlagwörter

labile iron poolnon-small cell lung cancerFTH1deferoxamineiron chelationDNA damagereplication stressATM signalingATR signalingoxidative stress

Zitieren

APA

Bayanbold, K. (2023). Manipulating labile iron to enhance the therapeutic response of NSCLC to chemoradiation therapy. Iowa Research Online (The University of Iowa). https://doi.org/10.25820/etd.006977

Vancouver

Bayanbold K. Manipulating labile iron to enhance the therapeutic response of NSCLC to chemoradiation therapy. Iowa Research Online (The University of Iowa). 2023. doi:10.25820/etd.006977

BibTeX
@article{Bayanbold2023,
  author = {Bayanbold, Khaliunaa},
  title = {Manipulating labile iron to enhance the therapeutic response of NSCLC to chemoradiation therapy},
  journal = {Iowa Research Online (The University of Iowa)},
  year = {2023},
  doi = {10.25820/etd.006977}
}
Kostenlos starten →